CAS 2247114-85-6

Adebrelimab

CAS : 2247114-85-6

Adebrelimab (SHR-1316) is a humanized monoclonal antibody targeting PD-L1 with antitumor activity for the study of solid tumors.

Degré de pureté : 97.8% (SDS-PAGE); 97.5% (SEC-HPLC) - 97.8% (SDS-PAGE); 97.5% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 145.54 kDa

Ref: TM-T76899